As Managing Partner at ZS Associates, Maria Whitman oversees global commercialization strategy and solutions, driving transformation across industries. She played a key role in creating Myelo, the IMF’s AI-powered chatbot for patients, care partners, and healthcare professionals. With nearly 25 years of experience, she specializes in oncology, cell and gene therapy, and rare diseases.

A founding leader of ZS’s strategy and transformation practice, Ms. Whitman has guided numerous organizations in enhancing healthcare impact. Her expertise is widely recognized, with her insights featured in “The Wall Street Journal” and industry publications. As an IMF board member, Ms. Whitman is committed to “dedicating her time and expertise to advancing the goals and mission of the IMF and being a strong representative for the IMF’s values” while supporting patients globally. She holds an MBA from Wharton and a BS from La Salle University.